Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Cooper

Showing results (131-140 of 144) with videos related to

Pageof 15
Sort By:
Acta Neuropathologica Communications|September 10, 2014
Behavioral deficits, early gliosis, dysmyelination and synaptic dysfunction in a mouse model of mucolipidosis IVYulia Grishchuk, Sarmi Sri, Nikita Rudinskiy, et al.
Cells|September 9, 2022
Modelling Neurological Diseases in Large Animals: Criteria for Model Selection and Clinical AssessmentSamantha L Eaton, Fraser Murdoch, Nina M Rzechorzek, et al.
Molecular Therapy. Methods & Clinical Development|June 9, 2015
A novel, long-lived, and highly engraftable immunodeficient mouse model of mucopolysaccharidosis type IDaniel C Mendez, Alexander E Stover, Anthony D Rangel, et al.
Orphanet Journal of Rare Diseases|March 11, 2026
Recommendations for the diagnosis and management of cln3 disease (batten disease) using the Delphi consensus methodologyJonathan W Mink, Heather R Adams, Rebecca Ahrens-Nicklas, et al.
Molecular Genetics and Metabolism|September 27, 2014
Nonclinical evaluation of CNS-administered TPP1 enzyme replacement in canine CLN2 neuronal ceroid lipofuscinosisBrian R Vuillemenot, Derek Kennedy, Jonathan D Cooper, et al.
Scientific Reports|February 9, 2020
Generation of light-producing somatic-transgenic mice using adeno-associated virus vectorsRajvinder Karda, Ahad A Rahim, Andrew M S Wong, et al.
Nature Communications|February 7, 2017
mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseasesMichela Palmieri, Rituraj Pal, Hemanth R Nelvagal, et al.
Nature Communications|June 14, 2017
Corrigendum: mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseasesMichela Palmieri, Rituraj Pal, Hemanth R Nelvagal, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Identifying and treating CLN3 disease outside the central nervous systemEwa A Ziółkowska, Albina Jablonka-Shariff, Letitia L Williams, et al.
Human Molecular Genetics|January 9, 2013
Cathepsin F mutations cause Type B Kufs disease, an adult-onset neuronal ceroid lipofuscinosisKatherine R Smith, Hans-Henrik M Dahl, Laura Canafoglia, et al.
Pageof 15

Showing results (131-140 of 144) with videos related to

Sort By:
Pageof 15
Acta Neuropathologica Communications|September 10, 2014
Behavioral deficits, early gliosis, dysmyelination and synaptic dysfunction in a mouse model of mucolipidosis IVYulia Grishchuk, Sarmi Sri, Nikita Rudinskiy, et al.
Cells|September 9, 2022
Modelling Neurological Diseases in Large Animals: Criteria for Model Selection and Clinical AssessmentSamantha L Eaton, Fraser Murdoch, Nina M Rzechorzek, et al.
Molecular Therapy. Methods & Clinical Development|June 9, 2015
A novel, long-lived, and highly engraftable immunodeficient mouse model of mucopolysaccharidosis type IDaniel C Mendez, Alexander E Stover, Anthony D Rangel, et al.
Orphanet Journal of Rare Diseases|March 11, 2026
Recommendations for the diagnosis and management of cln3 disease (batten disease) using the Delphi consensus methodologyJonathan W Mink, Heather R Adams, Rebecca Ahrens-Nicklas, et al.
Molecular Genetics and Metabolism|September 27, 2014
Nonclinical evaluation of CNS-administered TPP1 enzyme replacement in canine CLN2 neuronal ceroid lipofuscinosisBrian R Vuillemenot, Derek Kennedy, Jonathan D Cooper, et al.
Scientific Reports|February 9, 2020
Generation of light-producing somatic-transgenic mice using adeno-associated virus vectorsRajvinder Karda, Ahad A Rahim, Andrew M S Wong, et al.
Nature Communications|February 7, 2017
mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseasesMichela Palmieri, Rituraj Pal, Hemanth R Nelvagal, et al.
Nature Communications|June 14, 2017
Corrigendum: mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseasesMichela Palmieri, Rituraj Pal, Hemanth R Nelvagal, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Identifying and treating CLN3 disease outside the central nervous systemEwa A Ziółkowska, Albina Jablonka-Shariff, Letitia L Williams, et al.
Human Molecular Genetics|January 9, 2013
Cathepsin F mutations cause Type B Kufs disease, an adult-onset neuronal ceroid lipofuscinosisKatherine R Smith, Hans-Henrik M Dahl, Laura Canafoglia, et al.
Pageof 15